FourThought Financial, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
FourThought Financial, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$39,000
+85.7%
2,267
+1.6%
0.01%
+66.7%
Q2 2021$21,000
-12.5%
2,232
-1.4%
0.00%0.0%
Q1 2021$24,000
-35.1%
2,263
-10.5%
0.00%
-50.0%
Q4 2020$37,0002,5280.01%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
TWO SIGMA ADVISERS, LP 28,700$9,0000.00%
UBS Group AG 29,208$9,0000.00%
WELLS FARGO & COMPANY/MN 6,350$2,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders